# A Phase 1 Study of ISM4808 in Healthy Adult Subjects

> **NCT07415304** · PHASE1 · NOT_YET_RECRUITING · sponsor: **TaiGen Biotechnology Co., Ltd.** · enrollment: 86 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ISM4808
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07415304
- **Lead sponsor:** TaiGen Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-13
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07415304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07415304, "A Phase 1 Study of ISM4808 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07415304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*